Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

F George Tidmarsh


  • Director at Odonate Therapeutics Inc. (ODT), 2019-09-24
  • President, Ceo & Secretary at La Jolla Pharmaceutical Co (LJPC), 2019-04-17
  • Executive Director at Anavex Life Sciences Corp. (AVXL), 2012-02-10
  • Cso And Head Of R&d Operations at Spectrum Pharmaceuticals Inc (SPPI), 2011-02-15
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LJPC $5.85 436 Officer, Director 1,283,326 2019-01-07 Filing
LJPC $5.85 700 Officer, Director 1,282,890 2019-01-07 Filing
LJPC $5.85 397 Officer, Director 1,282,190 2019-01-07 Filing
LJPC $5.85 98 Officer, Director 1,281,793 2019-01-07 Filing
LJPC $5.85 287 Officer, Director 1,281,695 2019-01-07 Filing